Active Cold Chain Solutions for High-Value Pharma

scientist with equipment and science experiments, laboratory glassware containing chemical liquid for research or analyzing a sample into test tube in laboratory.

About the Case Study

Industry

SERVICES PROVIDED

The Challenge

A U.S.-headquartered pharmaceutical company, producing oncology treatments in Switzerland, sought a logistics partner that could provide visibility and the utmost attention to precision in delivering their high-value and sensitive product to the U.S. They required specialized and reliable cold chain service packages that would not only support their commercial strategy but, most importantly, preserve the stringent characteristics of the product.

The treatments needed to be transported within a controlled temperature range of +2°C to +8°C, +15°C to +25°C, or +2°C to +25°C, with zero tolerance for any deviation. An active container solution was identified as the best option to ensure product integrity throughout the supply chain.

The Solution

PSA BDP designed and executed an end-to-end cold chain strategy that combined advanced technology with proven global expertise. Active containers equipped with dry ice bunkers, fan-driven convection airflow, and thermostat-controlled heat exchangers provided precise temperature management throughout transit. Integrated alert systems and downloadable USB data enabled real-time visibility, compliance reporting, and proactive oversight at every stage.

The journey was managed seamlessly through PSA BDP’s global network: GDP-certified thermo trucks handled the first and last mile, while PSA BDP warehouses at both origin and destination ensured proper stuffing and unstuffing of active containers. Approved air carriers with direct flight routes were selected to minimize hand-offs and maintain full control of the shipment. The approach not only guaranteed regulatory compliance and product integrity but also aligned with the client’s sustainability objectives through optimized routing and mode selection.

The Result

Through this integrated approach, PSA BDP delivered safe, compliant, and efficient end-to-end management of the client’s high-value oncology treatments. The active cold chain solution ensured full adherence to temperature and regulatory requirements, while real-time visibility supported transparency and quality assurance at every stage.

By safeguarding product efficacy and maintaining consistency across multiple touchpoints, PSA BDP helped the client protect patient safety and uphold its commitment to uncompromised treatment quality.